The Isle of Man-based anti-aging biotech company is focusing on developing therapeutics for human longevity by partnering, creating, and investing in companies with anti-aging related projects.
According to 94% of physicians and 90% of hospitals in the survey, reports suggest that mobile technology in the healthcare sector is enhancing patients' safety and results. On the other hand, 63% reported ongoing challenges with a buy-in of general mobile adoption strategies and related enterprise technology execution
The United States, Department of Human & Health Services has been aiming to enhance patient care and health security for a long period of time. Recently the HHS selected eight accelerators to steer artificial intelligence innovation. The chosen accelerators will develop AI devices to solve challenging problems in daily patient care and health security.
Dr. Paul Curtin along with his colleagues from Icahn School of Medicine at Mount Sinai in New York City have discovered that autism spectrum disorder (ASD) can be predicted in advance, by looking at zinc and copper metabolic cycles in a baby’s teeth. This discovery could lead to the development of novel diagnostic tools with a 90% accuracy level.
Public locations have seen the deployment of six kiosks, called MedCenters, developed by MedAvail. These locations include grocery stores, pharmacies and clinics located in Phoenix and Tuscon partnering with Express Scripts. These MedCenters offer 24/7 access to online pharmacies and can be seen as a ‘pharma ATM’.
In a shocking discovery, a research team at Tokyo Medical and Dental University Hospital, Japan revealed that stroke patients belong to ‘O’ blood group were associated with higher death rates.
The research work under the lead investigator Amy Zheng of the Massachusetts General Hospital (MGH) Medical Practice Evaluation Center in Boston indicated that the Dolutegravir-based regimen would increase the life expectancy of HIV victims by 2.8 years and prevent 13,000 new HIV infections over 5 years. It was also revealed that this first-line treatment would be cost-effective in 2 years and cost-saving over 5 years.
This will be the second recall on a heart device this month Medtronic’s Heartware device and accessories was recalled a few days ago. This comes after Abbott issued a patch to negate cybersecurity issues 350,000 remote monitoring systems and pacemakers.
According to the FDA, if the antidote drugs are used on a patient, they could suffer from “allergic reactions, local irritation” and a wide number of cardiovascular issues, including restriction of blood supply to tissues. The FDA stated that there has not yet been any reports of patient harm from Naloxone.
This week Apple announced that researchers and app developers can now have access to a Health Record API (Application Programming Interface) to develop applications, with the permission to use the patient’s data to provide them with easy access to health records.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.